Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Jincao Tablets for chronic pelvic pain after pelvic inflammatory disease
ChiCTR2200058497Phase 3Not yet recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Jul 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Jincao in Pelviabdominal infection and chronic prostatitis (CP) (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoints: Visual analogue scale score for pain, Routine blood test and 5 more. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
Jincao
03
Conditions
Pelviabdominal infectionchronic prostatitis (CP)
Beyond the preview
Go deeper on ChiCTR2200058497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058497.